Home »
Academic Articles & Research Papers
Showing 20 of 110 academic articles
Arias V, Clubb JH, Kudling TV, Jirovec E et al. • Journal for immunotherapy of cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1136/jitc-2026-016430
PMC: PMC13735263
Wessam Eid, Fawzia Abo Ali, Sara Taha, Sara Zaki et al. • Zagazig University Medical Journal
(2022)
Total immunoglobulin E (IgE) has roles in allergy and anti-parasitic immunity. Recently IgE showed a major role in cancer immune surveillance; an increased risk of solid and blood malignancies has been associated with total IgE deficiency. ...
DOAJ
Open Access (DOAJ)
DOI: 10.21608/zumj.2022.130517.2541
Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena et al. • Frontiers in Immunology
(2025)
Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies, achieving remarkable clinical success with FDA-approved therapies targeting CD19 and BCMA. However, the extension of these successe...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2024.1489827
Zhen Wang, Honglei Guo, Yanqi Song, Aidi Wang et al. • Frontiers in Immunology
(2025)
Lung cancer is the most common malignant tumor in the world. Presently, there are still problems, including a high recurrence rate, resistance, and serious toxic side effects, even if conventional treatments like chemotherapy, radiotherapy,...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2025.1597686
Katharina Schindler, Katharina Eva Ruppel, Claudia Müller, Ulrike Koehl et al. • Molecular Therapy: Methods & Clinical Development
(2024)
Chimeric antigen receptor (CAR) T cell therapies have demonstrated significant successes in treating cancer. Currently, there are six approved CAR T cell products available on the market that target different malignancies of the B cell line...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.omtm.2024.101328
D.E. Milenic, B. Detrick, J.C. Reynolds, D. Colcher • The International Journal of Biological Markers
(1990)
Murine monoclonal antibodies (MAb) are currently being assessed for their utility as tools in cancer management. Anti-murine immunoglobulin responses have been observed in many patients receiving monoclonal antibody treatment. In this study...
DOAJ
Open Access (DOAJ)
DOI: 10.1177/172460089000500403
Zhongru Fan, Dongyu Han, Xin Fan, Lin Zhao • Frontiers in Immunology
(2023)
BackgroundOvarian cancer (OC) is one of the malignant tumors that poses a serious threat to women’s health. Natural killer (NK) cells are an integral part of the immune system and have the ability to kill tumor cells directly or participate...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2023.1308143
Olivera J. Finn • New England Journal of Medicine
(2008)
This review is a comprehensive account of the current status of tumor immunology, beginning with the identification of human tumor antigens and ending with a summary of clinical applications of what we know about the immunology of tumors....
OPENALEX
DOI: https://doi.org/10.1056/nejmra072739
Ladi Alik Kumar, K Sunand, Jitendra Debata, Gopal Krishna Padhy et al. • Journal of Bio-X Research
(2025)
Cancer is a disorder characterized by the abnormal growth of cells that increases uncontrollably over an extended period of time. Treating cancerous brain tumors remains among the most challenging tasks for researchers, as brain tumors are ...
DOAJ
Open Access (DOAJ)
DOI: 10.34133/jbioxresearch.0065
Sanjay Mishra, Manish Charan, Ajeet Kumar Verma, Bhuvaneswari Ramaswamy et al. • Frontiers in Cell and Developmental Biology
(2021)
Recent studies revealed that ethnic differences in mechanistic target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK-1/2) signaling pathways might be associated with the development and progression of different human mal...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fcell.2021.601929
Man Teng, Zi-Yu Zhou, Yongxiu Yao, Venugopal Nair et al. • Viruses
(2022)
Marek’s disease virus (MDV) is an important oncogenic α-herpesvirus that induces Marek’s disease (MD), characterized by severe immunosuppression and rapid-onset T-cell lymphomas in its natural chicken hosts. Historically, MD is regarded as ...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/v14092045
Julia Keller, Pascale Plaisancié, Edwin Fouché, Edwige-Marie Pralet et al. • Redox Experimental Medicine
(2025)
Objective: Colorectal cancer is a major public health issue for which dietary factors such as red and processed meat consumption seem to play a prominent role. Heme iron, which is present in important concentration in those food products, w...
DOAJ
Open Access (DOAJ)
DOI: 10.1530/REM-25-0001
Angel Chao, Ren-Chin Wu, Chiao-Yun Lin, Ting-Chang Chang et al. • Biomedical Journal
(2023)
Small cell neuroendocrine carcinoma of the cervix (SCNECC) is an uncommon but aggressive uterine malignancy, the cause of which is generally associated with human papillomavirus (HPV) infection. A lack of clinical trials and evidence-based ...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.bj.2023.100633
Varga C, Schaefer E • JMIR cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.2196/95949
PMC: PMC13739275
Fang L, Song J, Wang X, Wang F et al. • Frontiers in Immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1978134
PMC: PMC13736033
Shannon R. Stock, Joshua A. Parrish, Michael T. Burns, Jessica L. Janes et al. • Cancer Medicine
(2025)
ABSTRACT Purpose Accurate classification of prostate cancer (PC) disease states defined by the presence or absence of metastasis and castration resistance (CRPC) is critical but challenging in population‐based research. As chart review is n...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/cam4.71406
Giunta EF, Marini I, Grassi I, Nicolini S et al. • European journal of nuclear medicine and molecular imaging
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s00259-026-08173-x
PMC: PMC13727948
Sanjay Goswami, Kshama D. Dhobale, Ravindra D. Wavhale, Barnali Goswami et al. • Applied AI Letters
(2022)
Abstract The field of cancer nanomedicine has made significant progress, but its clinical translation is impeded by many challenges, such as the difficulty in analyzing intracellular anticancer drug release by the nanocarriers due to the la...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/ail2.50
Ji Su Hwang, Seok Gi Kim, Tae Hwan Shin, Yong Eun Jang et al. • Pharmaceutics
(2022)
Cancer is a group of diseases causing abnormal cell growth, altering the genome, and invading or spreading to other parts of the body. Among therapeutic peptide drugs, anticancer peptides (ACPs) have been considered to target and kill cance...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/pharmaceutics14050997
Sloan AR, Bukenya G, Tannish GP, Silver DJ et al. • Cancer cell
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.ccell.2026.10.004
PMC: PMC13739064